Top Page
Alexium International Group
(Sydney:AJX)
Alexium International Group (AJX) vs. iShares MSCI Australia ETF (EWA)
Alexium International Group Business Overview & Revenue Model
Alexium International Group Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.55M | 3.92M | 5.89M | 7.19M | 8.14M | 7.29M |
| Gross Profit | 2.04M | 1.69M | 2.64M | 2.81M | 3.32M | 2.65M |
| EBITDA | -1.70M | -3.25M | -962.00K | -1.38M | -1.54M | 147.52K |
| Net Income | -2.14M | -3.93M | -2.76M | -2.95M | -3.36M | -1.45M |
Balance Sheet | ||||||
| Total Assets | 5.23M | 2.88M | 5.23M | 5.37M | 6.40M | 10.49M |
| Cash, Cash Equivalents and Short-Term Investments | 2.05M | 662.45K | 2.05M | 511.78K | 1.02M | 2.94M |
| Total Debt | 969.43K | 2.55M | 969.43K | 4.69M | 3.85M | 3.46M |
| Total Liabilities | 1.93M | 3.28M | 1.93M | 6.35M | 4.83M | 6.31M |
| Stockholders Equity | 3.30M | -402.08K | 3.30M | -980.26K | 1.57M | 4.18M |
Cash Flow | ||||||
| Free Cash Flow | -1.35M | -2.80M | -1.35M | -1.49M | -1.93M | -1.51M |
| Operating Cash Flow | -1.19M | -2.58M | -1.19M | -1.10M | -1.57M | -1.39M |
| Investing Cash Flow | -156.22K | -218.09K | -156.22K | -385.41K | -353.35K | -882.65K |
| Financing Cash Flow | 2.91M | 1.42M | 2.91M | 992.85K | 74.01K | 323.38K |
Alexium International Group Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | AU$40.30M | -5.14 | -67.76% | ― | 7.08% | 33.70% | |
53 Neutral | AU$85.54M | -96.74 | -1.75% | ― | -5.37% | -140.00% | |
53 Neutral | AU$21.86M | -7.79 | -63.81% | ― | ― | 52.66% | |
49 Neutral | AU$295.34M | -14.24 | -22.28% | ― | 16.47% | 29.53% | |
41 Neutral | AU$28.42M | -2.62 | -869.14% | ― | 340.27% | 19.44% | |
37 Underperform | AU$16.60M | -2.78 | -263.52% | ― | -32.85% | 28.00% |
Alexium International Group Corporate Events
Alexium International Group Limited has opened a non-renounceable pro-rata entitlement offer, giving eligible shareholders in selected jurisdictions the right to subscribe for 3.4414 new shares for every five existing shares at an offer price of $0.006 per share. The offer, which closes on 16 January 2026, is being conducted entirely online via the company’s share registry, with no hard copies of documents dispatched, signalling a cost-conscious and digital-first approach to capital raising that may help strengthen its balance sheet and support ongoing operations in its specialised performance chemicals markets.
The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.
Alexium International Group Limited has announced the issuance of 29,262,504 ordinary shares without disclosure under section 708A(5)(e) of the Corporations Act. The company reaffirmed its compliance with relevant provisions of the Act while confirming no additional excluded information needs disclosure. This move is expected to bolster the company’s operational and financial positioning amidst its focus on innovative chemical solutions for diverse industries.
The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.
Alexium International Group Limited has announced a change in the director’s interest notice, specifically regarding Simon Colinton Moore. Mr. Moore has acquired 9,715,591 Ordinary Fully Paid Shares in lieu of director remuneration for the period from July 1, 2025, to November 30, 2025. These shares are held by Colinton Capital Partners Pty Ltd, which became a majority shareholder following participation in the company’s April 2024 Entitlement Offer. This change reflects the company’s ongoing efforts to align director compensation with shareholder interests.
The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.
Alexium International Group Limited has announced a change in the director’s interest, with Paul Stenson acquiring 3,157,570 ordinary fully paid shares. These shares were issued in lieu of director remuneration for the period from July to November 2025, as approved by shareholders at the 2025 Annual General Meeting. This move reflects the company’s ongoing efforts to align management interests with shareholder value, potentially impacting its governance and financial strategies.
The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.
Alexium International Group Limited has announced a change in the director’s interest, specifically for Director T. Randall Lane. The company issued 3,157,570 Ordinary Fully Paid Shares in lieu of director remuneration for the period from July 1, 2025, to November 30, 2025, as approved by shareholders at the 2025 Annual General Meeting. This change increases Lane’s total holdings to 11,057,313 Ordinary Fully Paid Shares. This move reflects the company’s strategy to align director compensation with shareholder interests and maintain financial flexibility.
The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.
Alexium International Group Limited announced a change in the director’s interest, with James Williamson acquiring additional shares. This acquisition was made as part of director remuneration, approved at the 2025 Annual General Meeting, indicating a strategic move to align director interests with company performance.
The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.
Alexium International Group Limited has announced the issuance of 29,262,504 ordinary fully paid shares as part of director remuneration, approved by shareholders at the recent Annual General Meeting. This move aims to align the interests of the company’s leadership with its shareholders and could potentially enhance the company’s market positioning by demonstrating a commitment to governance and shareholder value.
The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.
Alexium International Group Limited has announced an update to a previous announcement regarding a proposed issue of securities. The update aligns the issue date with the Offer Document, ensuring compliance with ASX Listing Rules. This non-renounceable pro rata issue reflects the company’s strategic move to enhance its financial flexibility and strengthen its market position.
The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.
Alexium International Group Limited announced a non-renounceable pro-rata entitlement offer to raise approximately $6.77 million by issuing new shares to eligible shareholders. The offer, underwritten by Colinton Capital Partners and others, aims to maintain shareholder control while potentially diluting those who do not fully subscribe. The impact on company control will depend on shareholder participation, with the underwriters stepping in to cover any shortfall.
The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.
Alexium International Group Limited has released an updated Entitlement Offer booklet, which includes a revised timetable and minor changes. The company is conducting a pro rata non-renounceable Rights Issue to raise approximately $6.77 million before costs, offering new shares to eligible shareholders. This initiative is underwritten by Colinton Capital Partners Pty Ltd and others, and aims to strengthen the company’s financial position, potentially impacting its market presence and stakeholder interests.
The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.
Alexium International Group Limited has announced a pro rata non-renounceable rights issue to raise approximately $6.77 million. The offer, underwritten by Colinton Capital Partners and other partners, will allow eligible shareholders to purchase new shares at a price of $0.006 each. This capital raising initiative is aimed at bolstering the company’s financial position and supporting its ongoing operations, potentially impacting its market presence and providing opportunities for growth.
The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.
Alexium International Group Limited has announced a significant change in the securities held by its director, William Timothy Blackburn. On December 12, 2025, Blackburn’s Share Appreciation Rights increased from 32,575,149 to 99,067,084, following the approval of Resolution 12 at the 2025 AGM. This change reflects a strategic move by the company to align director interests with company performance, potentially impacting the company’s market positioning and stakeholder confidence.
The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.
Alexium International Group Limited announced the results of its Annual General Meeting, detailing the outcomes of various resolutions voted on by its shareholders. Key resolutions included the adoption of the remuneration report, re-election and election of directors, approval of the employee securities incentive plan, and the issuance of shares in lieu of director fees. All resolutions were carried, indicating strong shareholder support and potentially positive implications for the company’s governance and strategic direction.
Alexium International Group Limited held its 2025 Annual General Meeting, where key company figures such as Interim Chair Simon Moore and CEO William Blackburn were present. The meeting focused on the company’s strategic direction and leadership, with implications for its future operations and market positioning.
Alexium International Group Limited announced the livestream link for its upcoming Annual General Meeting (AGM) scheduled for 21 November 2025. The meeting will be held in Sydney, Australia, and virtual attendees can participate by asking questions through the Teams platform, although voting requires in-person attendance. This announcement facilitates stakeholder engagement by providing a virtual platform for participation, reflecting the company’s commitment to transparency and accessibility.
Alexium International Group Limited announced the resignation of its Vice President of Finance, Lisa Hubka, effective January 7, 2026, with Heather White appointed as her successor. This leadership change is part of a strategic transition to ensure continuity in financial management, reflecting the company’s ongoing commitment to innovation and market leadership in performance chemicals.
Alexium International Group Limited has announced the arrangements for its 2025 Annual General Meeting, inviting shareholders to participate in person or via a live stream. The meeting will be held on November 21, 2025, and shareholders are encouraged to submit proxy forms online by November 19, 2025. This meeting is a critical opportunity for stakeholders to engage with the company’s strategic direction and performance.
Alexium International Group Limited has announced an investor webinar scheduled for October 16, 2025, in Sydney and October 15, 2025, in Greer. The event will feature presentations from key company leaders, including the Interim Chair, CEO, and Vice President of Finance. This initiative aims to engage shareholders by allowing them to submit questions during the webinar, potentially enhancing transparency and communication with stakeholders.
Alexium International Group Limited has announced a change in the director’s interest, specifically concerning William Timothy Blackburn. The change involves the lapse of 22,843,648 Share Appreciation Rights, resulting in a decrease of securities held by the director. This adjustment reflects the company’s ongoing management of executive compensation and may influence shareholder perceptions regarding executive incentives and alignment with company performance.
Alexium International Group Limited announced the cessation of 32,476,019 share appreciation rights due to the expiry of options or other convertible securities without exercise or conversion as of September 23, 2025. This development may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and market positioning.